S100B and Alzheimer disease: Similar to these results are the investigations of Yin and Stover, who introduced Aabs for AD diagnosing and monitoring, considering the qualitative changes in the levels of these antibodies with disease progression: amyloid-β precursor proteins, τ protein, S100b, and phospholipid [137].